Granted Patent
B2
US 9,498,485 · App. 14/839,820 · Granted Nov 22, 2016
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
Inventors:
Mahesh V. Patel (Salt Lake City, UT); Nachiappan Chidambaram (Sandy, UT); Satish Kumar Nachaegari (Salt Lake City, UT); Srinivasan Venkateshwaran (Salt Lake City, UT); Joel Frank (Sandy, UT)
Assignee:
LIPOCINE INC.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Disclosed are bioavailable solid state (17-β)-Hydroxy-4-Androsten-3-one esters suitable for pharmaceutical uses and administration to mammals in need of (17-β)-Hydroxy-4-Androsten-3-one.
Claims (1)
1. A solid state (17-β)-3-Oxoandrost-4-en-17-yl tridecanoate suitable for administration to human subject in need of (17-β)-Hydroxy-4-Androstenes-3-one which is a crystalline (17-β)-3-Oxoandrost-4-en-17-yl tridecanoate form having a powder x-ray diffraction spectra substantially the same as that shown in FIG. 6 .
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 22, 2017
From: PATEL, MAHESH V.; CHIDAMBARAM, NACHIAPPAN; NACHAEGARI, SATISH KUMAR; VENKATESHWARAN, SRINIVASAN; FRANK, JOEL; PORTLOCK, AMY JO
To: LIPOCINE INC.
Reel/Frame 041688/0231 →
Continuity (2)
Provisional Application
62043337
· Aug 28, 2014